Adaptin Bio (APTN) Payables (2022 - 2026)

Adaptin Bio's Payables history runs 5 years deep, the most recent figure standing at $1.4 million for Q1 2026.

• In Q1 2026, Payables rose 319.29% year-over-year to $1.4 million; the TTM figure through Mar 2026 stood at $1.4 million (up 319.29% YoY), while the FY2025 annual figure was $1.5 million, down 7.58% from the prior year.
• Payables came in at $1.4 million for Q1 2026 at Adaptin Bio, down from $1.5 million in the prior quarter.
• In the past five years, Payables ranged from a high of $1.6 million in Q4 2024 to a low of $17500.0 in Q4 2022.
• A 5-year average of $624326.0 and a median of $258973.5 in 2024 frame the typical range for Payables.
• Across the five-year window, Payables jumped 1912.97% in 2024 and dropped 7.58% in 2025, its largest moves.
• Adaptin Bio's Payables stood at $17500.0 in 2022, then surged by 364.44% to $81277.0 in 2023, then surged by 1912.97% to $1.6 million in 2024, then dropped by 7.58% to $1.5 million in 2025, then decreased by 9.31% to $1.4 million in 2026.
• According to Business Quant data, Payables over the past three periods registered $1.4 million, $1.5 million, and $1.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison